Escalating to medium‐ versus high‐efficacy disease modifying therapy after low‐efficacy treatment in relapsing remitting multiple sclerosis. - Müller, Jannis; Roos, Izanne; Kalincik, Tomas; Lorscheider, Johannes; Galli, Edoardo; Benkert, Pascal; Schädelin, Sabine; Sharmin, Sifat; Einsiedler, Maximilian; Hänni, Peter; Schmid, Jürg; Kuhle, Jens; et al. (Brain & Behavior, 2024)